TIGOS-LS, an open-label, randomized study of BMS-986489 vs durvalumab as consolidation therapy following chemoradiotherapy in limited-stage small-cell lung cancer.

Authors: Melissa Lynne Johnson, Ticiana Leal, Jerome H. Goldschmidt, Sarah Yue Wang, William E Brady, Maen A. Hussein, Caressa Lietman, Hillarie Windish, Christophe Y. Calvet, Lola Dosunmu, Alisha Maniar, LaRee Tracy, Neal E. Ready

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps8124

Source: Full article

---

Abstract

TPS8124